The European Clinical, Molecular, and Pathological (ECMP) Criteria and the 2007/2008 Revisions of the World Health Organization for the Diagnosis, Classification, and Staging of Prefibrotic Myeloproliferative Neoplasms Carrying the JAK2V617F Mutation.

Saved in:

Bibliographic Details
Title:	The European Clinical, Molecular, and Pathological (ECMP) Criteria and the 2007/2008 Revisions of the World Health Organization for the Diagnosis, Classification, and Staging of Prefibrotic Myeloproliferative Neoplasms Carrying the JAK2^V617F Mutation.
Alternate Title:	JAK2V617F Mutasyonu Bulunan Prefibrotik Myeloproliferatif Neoplazmların Tanı, Sınıflandırma ve Evrelendirmesinde Dünya Sağlık Örgütü Kriterlerinin 2007/2008 Gözden Geçirilmesi ve Avrupa Klinik, Moleküler ve Patolojik (ECMP) Kriterleri.
Authors:	Michiels, Jan Jacques^1,2 goodheartcenter@upcmail.nl, Kate, Fibo Ten³, Lam, King H.³, Schroyens, Wilfried¹, Berneman, Zwi¹, De Raeve, Hendrik⁴
Source:	Turkish Journal of Hematology. 2014, Vol. 31 Issue 3, p239-254. 16p.
Database:	Academic Search Ultimate

Description
ISSN:	13007777
DOI:	10.4274/tjh.2013.0131